Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Measures belly pressure during heart rhythm ablation procedures

Tests a catheter device that measures belly pressure during heart rhythm treatment in adults.

Plain-language title generated from the registry record
Registry title: Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter

Key facts

Where
Winston-Salem, United StatesSee the site

Where in United States

  • Wake Forest Health SciencesWinston-Salem, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Wake Forest University Health Sciences
Trial code
NCT06876896
Record updated
19 March 2026
Original description
The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.Read full original descriptionShow less

Comparative Study of Intra-abdominal Pressure Using Accuryn Monitoring System During Pulsed Field Ablation (PFA) for Treatment of Atrial Fibrillation and/or Atrial Flutter Under Sedation.

The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.

Inclusion: Adult patients receiving pulse field ablation procedures for standard of care treatment of atrial fibrillation and/or atrial flutter; Eligible for Foley catheter placement with no contraindications to Intra-abdominal pressure (IAP) monitoring.

Exclusion: History of intra-abdominal surgery within the past 6 months; Known contraindications to bladder catheterization or catheter ablation; history of prostate issues / Benign prostatic hyperplasia (BPH) or frequent urinary tract infections; History of chronic obstructive pulmonary disease (COPD) with home oxygen use; Patients under the age of 18 will be excluded; Pregnant or breastfeeding individuals.

ClinicalTrials.gov NCT06876896